These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1579807)

  • 1. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
    Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
    Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefuroxime axetil in the treatment of sinusitis. A review.
    Pakes GE; Graham JA; Rauch AM; Collins JJ
    Arch Fam Med; 1994 Feb; 3(2):165-75. PubMed ID: 7994439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefuroxime into bronchial mucosa following oral administration of cefuroxime axetil.
    Winter J; Dhillon P
    J Antimicrob Chemother; 1991 Apr; 27(4):556-8. PubMed ID: 1856136
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetration of cefuroxime into chronically inflamed sinus mucosa.
    Dinis PB; Monteiro MC; Lobato R; Martins ML; Gomes A
    Laryngoscope; 1999 Nov; 109(11):1841-7. PubMed ID: 10569419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of oral cefuroxime axetil into the human aqueous humor.
    Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
    Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
    Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
    Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R; Gehanno P; Nikolaidis P; Bagger-Sjöbäck D; Ibanez JM; Hampel B; Sommerauer B
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stepwise therapy of community-acquired pneumonia. Results of cefuroxime and cefuroxime axetil study].
    Iakovlev SV; Suvorova MP; Dvoretskiĭ LI; Vlasenko NA; Shakhova TV
    Antibiot Khimioter; 1998; 43(6):7-11. PubMed ID: 9644527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefuroxime axetil].
    Matsumoto F; Oizumi K
    Jpn J Antibiot; 1988 Sep; 41(9):1181-93. PubMed ID: 3071614
    [No Abstract]   [Full Text] [Related]  

  • 11. Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
    Schleupner CJ; Anthony WC; Tan J; File TM; Lifland P; Craig W; Vogelman B
    Arch Intern Med; 1988 Feb; 148(2):343-8. PubMed ID: 3277562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL; Whalen E; Echols RM; Heyd A
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
    Brink HS; Huisman RM; Geerlings W; de Jong PE
    Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults. Comparative study with cefaclor].
    Freche C; Fombeur JP; Pappo M
    Therapie; 1988; 43 Suppl 4():365-8. PubMed ID: 3222778
    [No Abstract]   [Full Text] [Related]  

  • 15. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
    Silley P; Monsey D; Harris AM
    J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
    James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue penetration following orally administered cefuroxime axetil.
    Wise R
    J Chemother; 1989 Jul; 1(4 Suppl):515-6. PubMed ID: 16312510
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amoxycillin-clavulanic acid and cefuroxime axetil in the treatment of acute sinusitis. A clinical, radiological and bacteriological evaluation].
    Olmo A; Sabater F; Broto J; Traserra J
    Acta Otorrinolaringol Esp; 1994; 45(1):25-9. PubMed ID: 8204290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
    Upchurch J; Rosemore M; Tosiello R; Kowalsky S; Echols R
    Otolaryngol Head Neck Surg; 2006 Oct; 135(4):511-7. PubMed ID: 17011409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice.
    Brodie DP; Knight S; Cunningham K
    J Int Med Res; 1989; 17(6):547-51. PubMed ID: 2628131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.